Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks - Yahoo Finance

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks  Yahoo FinanceEli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand  CNBCEli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected  Yahoo FinanceEli Lilly’s stock falls as weight-loss drug sales disappoint  MarketWatchLilly 2024 Sales Miss Estimate as Weight-Loss Drugs Slow  Bloomberg

Jan 14, 2025 - 17:19
 0
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks - Yahoo Finance
  1. Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks  Yahoo Finance
  2. Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand  CNBC
  3. Eli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected  Yahoo Finance
  4. Eli Lilly’s stock falls as weight-loss drug sales disappoint  MarketWatch
  5. Lilly 2024 Sales Miss Estimate as Weight-Loss Drugs Slow  Bloomberg

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow